The preprint observational study using U.K. health system data also found the Pfizer-BioNTech COVID-19 vaccine provided children and teens with only about 14 to 15 weeks of protection against testing positive for the virus.by Brenda Baletti, Ph.D.
The Pfizer-BioNTech COVID-19 vaccine provided children and teens in England with only about 14 to 15 weeks of protection against testing positive for the virus, according to a preprint study of over 1.7 million children ages 5 to 15 in the English National Healthcare System (NHS).
Researchers investigating the safety and effectiveness of Pfizer’s vaccine in fully vaccinated, partially vaccinated, and unvaccinated children and teens, also found cases of myocarditis and pericarditis only in vaccinated children.
“This study clearly shows that Pfizer’s COVID vaccine provides almost no benefit to children and adolescents, but does increase their risk of myocarditis and pericarditis,” said Brian Hooker, Ph.D., chief scientific officer of Children’s Health Defense. “It begs the question: Why does the CDC continue to recommend these unlicensed shots for kids? Where is the data they use to support their statement that the benefits of these vaccines outweigh the risks?”